12
thousand+
well done operations using Normacorsolution
20
+ centers
use the solution during operations
1 000
+ cases
enrolled in the patient registry
13
countries
Normacor cardioplegia patents were obtained in Europe, Asia, and America
8
original clinical trials
2
trials approved by the Russian Ministry of Health
12
+
publications in Russian and international journals
0
adverse reactions in the pharmacovigilance national database
A solution with proven safety and efficacy
Evidence based
Cardiac protection under normothermia conditions
About the solution
No reperfusion injury
For operations of any complexity
Self-restoration of rhythm
NORMACOR was developed in collaboration with the ChemRar Group as an open-heart medicine in normothermic conditions.
The drug contains an effective formula of components that allows for surgery under normothermia and moderate hypothermia. It virtually eliminates ischemia and reperfusion injury, providing a high degree of myocardial protection during any type and comlexity of surgery.
SOLUTION NO. 1
High-potassium
Used for rapid induction of asystole at the beginning of the operation. It makes sure that the cardiac arrest is controlled and predictable.
SOLUTION NO. 2
Low-potassium
Used for maintenance of asystole phase. Provides stable myocardial protection throughout the entire surgery.
Cardioplegia delivery systems design options
CSP Perfusion sets
Available in five variants: for blood and crystalloid cardioplegia, with usage of one or two solutions and perfusate thermoregulation.
Variations of Perfusion sets
Cardio System Pharma
CSP.1
Compatible with Normacor
Compatible with Normacor
Blood · normal/moderate hypothermia · up to 2 solutions
CSP.2
Blood · hypothermic · 2 solutions
CSP.3
Compatible with Normacor
Compatible with Normacor
Blood · normal/moderate hypothermia · 1 solution
CSP.6
Crystalloid · 1 solution
CSP.4
Crystalloid · up to 2 solutions
Characteristics of the CSP delivery systems | Perfusion sets
Structure of delivery systems
Each component is designed for safety—from the air trap to the universal connectors for the oxygenator. Select an option to view its components.
Three-way valve
removes air from circuit
Y-connector
connects the blood and cardioplegia solution circuits
Silicone tubes
connect to roller pumps
Double-channel polymer needles
firm connection to cardioplegia containers
1/4" connector
connects to an oxygenator
Air Trap
safely eliminates air bubbles out of the fluid
CSP.1
Three-way valve
removes air from circuit
Heat exchanger
cools the perfusate
Silicone tubes
connect to roller pumps
Double-channel polymer needles
firm connection to cardioplegia containers
1/4" connector
connects to an oxygenator
Air Trap
safely eliminates air bubbles out of the fluid
CSP.2
Three-way valve
removes air from circuit
Y-connector
connects the blood and cardioplegia solution circuits
Silicone tubes
connect to roller pumps
Double-channel polymer needle
firm connection to a cardioplegia container
1/4" connector
для подключения к оксигенатору
Air Trap
safely eliminates air bubbles out of the fluid
CSP.3
Three-way valve
removes air from circuit
Luer ML
connects to a cardioplegic cannula
Silicone tube
connects to a roller pump
Double-channel polymer needles
firm connection to cardioplegia containers
Invasive pressure monitoring line
Air Trap
safely eliminates air bubbles out of the fluid
CSP.4
Three-way valve
removes air from circuit
Luer ML
connects to a cardioplegic cannula
Silicone tube
connects to a roller pump
Double-channel polymer needle
firm connection to a cardioplegia container
Invasive pressure monitoring line
Air Trap
safely eliminates air bubbles out of the fluid
CSP.6
Contact us
Contacts
We are open to collaboration with сardiothoracic surgery teams, and provide convenient feedback on pharmacovigilance.
Report an adverse reaction
If you have experienced any adverse reactions while using the product from JSC CardioSystemPharma, please fill out the form below.
Collaborate with us!
We are interested in collaboration within clinical trials, observational programs, educational projects and publication activity in the field of cardiac surgery and anesthesiology.
JSC "CARDIOSYSTEMPHARMA"
Owner LP-No.(015032)-(RG-RU)
Owner LP-No.(015032)-(RG-RU)
2a-1, Rabochaya, St. Khimki, Moscow Region, 141401 Russia
© 2026 АО «КардиоСистемФарма». Все права защищены.
Мы используем куки для работы сайта